neurofibromatosis type 1 - mcgovern medical school...• neurofibromatosis type 1 is an autosomal...
TRANSCRIPT
Neurofibromatosis Type 1
Megan Mont
9/18/2019
Diagnostic Radiology: RAD 4001
Nicholas M. Beckmann, MD
McGovern Medical School
Clinical History
15-year-old male initially seeing PCP for left leg pain while playing soccer. Patient has long standing history of a skin nodule along the posterior left thigh. No other pertinent medical history. Mother has history of neurofibromatosis type 1.
McGovern Medical School
femur femur
tibia tibiafibula fibula
patella
Lytic lesion with surrounding
sclerosis
McGovern Medical School
T2 T2
femur femur
tibia tibia
Quadriceps tendon
Patellar tendon
patella
PCL
meniscus
Biceps femoris
Popliteus
Soleus
Gastrocnemius
Vastus intermedius
Vastus medialis
Vastus lateralis
Sartorius
Extensor digitorum longus
Mixed high and low T2
signal
McGovern Medical School
PD T1 post-contrast
Biceps femoris (long head)
Vastus medialis
Vastus lateralis
Semimembranosus
Gracilis
Sartorius
Femur (with lesion)
Popliteal artery and vein
Tibial nerve(with lesion)
Common peroneal nerve(with lesion)
Enhancing skin nodule
McGovern Medical School
PD T1 post-contrast
Biceps femoris (long head)
Semitendinosus
Semimembranosus
Sartorius
Gracilis
Adductor longus
Adductor magnus
Biceps femoris (short head)
Rectus femoris
Vastus lateralis
Vastus intermedius
Vastus medialisFemoral artery and vein
Sciatic nerve
Femur
Enhancing intermuscular
nodule
McGovern Medical School
PD
Tibialis anterior
Fibula
Tibia
Extensor hallucis longus
Extensor digitorum longus
Tibialis anterior artery and vein
Tibialis posterior
Peroneal artery and veinFlexor hallucis longus
Peroneus longus et brevis
Tibial nerve(with lesion)
Sural nerve(with lesion)
McGovern Medical School
Key Imaging Findings
• Lytic lesion in the distal femur metadiaphysis• X-ray: septations, sclerotic rim
• MRI: Lobulated margins and mixed high and very low T2 signal
• Skin nodule in the posterior distal thigh • MRI: high signal on proton density images with diffuse avid enhancement
• Hamstring, tibial nerve, and peroneal nerve nodules • MRI: increased PD signal and avid enhancement
McGovern Medical School
Differential Diagnosis
• Lytic lesion with surrounding sclerosis:• Non-ossifying fibroma (a.k.a. fibroxanthoma)
• Osteoid Osteoma / Osteoblastoma
• Brodie abscess (subacute pyogenic osteomyelitis)
• Enhancing lesions:• Plexiform neurofibroma
• Diffuse cutaneous neurofibroma
• Schwannoma
McGovern Medical School
Discussion• Most likely diagnosis: Neurofibromatosis Type 1 with non-ossifying
fibroma and plexiform neurofibroma (1)• “Von Recklinghousen disease”• Mutation in or deletion of NF1 gene• Autosomal dominant
• NF1 encodes neurofibromin and negatively regulates RAS-MAPK signaling, responsible for cell cycle regulation (2)
• Mutations in NF1 can lead to a variety of tumors
• NIH diagnostic criteria, must include at least 2 of the following: (1)• café-au-lait macules, axillary/inguinal freckling, optic glioma, Lisch nodules,
neurofibromas, distinctive osseous lesion, first degree relative with NF1
McGovern Medical School
Discussion
• Jaffe-Campanacci Syndrome (3)• Characterized by features of NF1 and multiple non-ossifying fibromas
• Rare syndrome: 0.4 -0.5% of patients with multiple NOFs
• Genetic profile not yet determined, could be a subtype of NF1
• Over 50% risk of pathologic fracture
• Treatment (3)• Curettage and bone grafting of NOFs to prevent fracture
• Consider osseous screening for all newly diagnosed NF1 patients
McGovern Medical School
Final Diagnosis: NF1
• Curettage of the femur lesion was performed with a pathologic diagnosis of non-ossifying fibroma
• The large nodule at the skin surface was also resected with pathologic diagnosis of plexiform neurofibroma.
• The nodules throughout the tibial and peroneal nerves are consistent with additional neurofibromas, as is the nodule in the hamstring muscles.
• Given mother’s history of NF1 and plexiform neurofibroma, the diagnosis of NF1 can be made in this patient.
McGovern Medical School
Treatment
• Curettage and bone grafting of the femur lesion was performed
• After curettage, the resultant defect usually fills and heals, even without grafting (4)
• Lesions > 70 cm are more likely to suffer complications including postoperative fracture and insufficient healing
• Surgical intervention can be considered to prevent both fracture and deformity (4)
McGovern Medical School
ACR appropriateness Criteria• Chronic knee pain (5)
McGovern Medical School
ACR appropriateness Criteria• Primary Bone Tumors (5)
• Within guidelines!
McGovern Medical School
Imaging Cost Calculation
• Average study cost in Houston, TX without insurance (6):• X-ray knee: $73 ($60-$140)
• MRI Lower Extremity: $543 ($420 - $1100)
• TOTAL: $616• Low estimate: $480
• High estimate: $1240
McGovern Medical School
Take Home Points
• Neurofibromatosis Type 1 is an autosomal dominant disorder that is rarely associated with non-ossifying fibromas.
• NOFs appear as lytic lesions with surrounding sclerosis that have a mix of high and very low T2 signal.
• Consider osseous screening for patients with newly diagnosed Neurofibromatosis Type 1 to avoid pathologic fractures secondary to non-ossifying fibromas.
McGovern Medical School
References1. Ferner RE, Huson SM, Thomas N, et al. Guidelines for the diagnosis and management
of individuals with neurofibromatosis 1. J Med Genet. 2007;44(2):81–88. doi:10.1136/jmg.2006.045906
2. Bovée JV, Hogendoorn PC. Non-ossifying fibroma: A RAS-MAPK driven benign bone neoplasm. J Pathol. 2019;248(2):127–130. doi:10.1002/path.5259
3. Cherix, S., Bildé, Y., Becce, F., Letovanec, I., Rüdiger, H., & Cherix, S. (2014). Multiple non-ossifying fibromas as a cause of pathological femoral fracture in Jaffe-Campanaccisyndrome. BMC Musculoskeletal Disorders, 15(1), 218–218. https://doi.org/10.1186/1471-2474-15-218
4. Kundu ZS, Gupta V, Sangwan SS, Rana P. Curettage of benign bone tumors and tumor like lesions: A retrospective analysis. Indian J Orthop. 2013;47(3):295–301. doi:10.4103/0019-5413.111507
5. https://acsearch.acr.org/list
6. Newchoicehealth.com
Questions?